Cargando…

Significant Weight Loss in a Patient Taking Olmesartan: An Unusual Case Report

OBJECTIVE: Olmesartan-induced enteropathy consists a syndrome that mimics celiac disease both clinically and histologically. Cases of this entity have sporadically been reported since 2012 and are usually characterized by severe diarrhea and malabsorption, followed by significant weight loss. CASE R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Makri, Andromachi, Florentin, Matilda, Elisaf, Moses S., Liamis, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865051/ https://www.ncbi.nlm.nih.gov/pubmed/30848210 http://dx.doi.org/10.2174/1574886314666190307142111

Ejemplares similares

Hyponatremia in the elderly: challenges and solutions
por: Filippatos, Theodosios D, et al.
Publicado: (2017)

Thiazide–associated hyponatremia in the elderly: what the clinician needs to know
por: Liamis, George, et al.
Publicado: (2016)

A review of drug-induced hypernatraemia
por: Liamis, George, et al.
Publicado: (2009)

Hyponatremia in Patients with Hematologic Diseases
por: Koumpis, Epameinondas, et al.
Publicado: (2020)

Early Investigational and Experimental Therapeutics for the Treatment of Hypertriglyceridemia
por: Parthymos, Ioannis, et al.
Publicado: (2022)

No effect of fenugreek, bergamot and olive leaf extract on glucose homeostasis in patients with prediabetes: a randomized double-blind placebo-controlled study
por: Florentin, Matilda, et al.
Publicado: (2019)

Hyperemesis Gravidarum: A Benign Condition of Pregnancy or a Challenging Metabolic Disorder?
por: Florentin, Matilda, et al.
Publicado: (2020)

An overview of diagnosis and management of drug‐induced hypomagnesemia
por: Liamis, George, et al.
Publicado: (2021)

Spruelike Enteropathy Associated with Olmesartan: An Unusual Case of Severe Diarrhea
por: Dreifuss, Stephanie E., et al.
Publicado: (2013)

Effects of Lipid-Modifying and Other Drugs on Lipoprotein(a) Levels—Potent Clinical Implications
por: Koutsogianni, Amalia Despoina, et al.
Publicado: (2023)

Olmesartan-Induced Enteropathy: A Report of an Unusual Cause of Chronic Diarrhea
por: Sotiropoulos, Christos, et al.
Publicado: (2021)

Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss
por: Gonakoti, Sripriya, et al.
Publicado: (2019)

Olmesartan-Induced Enteropathy: An Unusual Cause of Villous Atrophy
por: Eusébio, Marta, et al.
Publicado: (2015)

The relationship of vitamin D with non-traditional risk factors for cardiovascular disease in subjects with metabolic syndrome
por: Makariou, Stefania, et al.
Publicado: (2012)

Duodenal Villous Atrophy in a TTG-Negative Patient Taking Olmesartan: A Case Report and Review of the Literature
por: Kulai, Tasha, et al.
Publicado: (2016)

Olmesartan medoxomil: Allergic reaction: case report
Publicado: (2022)

A Case Report of Olmesartan-Induced Enteropathy
por: Daines, Benjamin S, et al.
Publicado: (2021)

Olmesartan-Induced Enteropathy: A Case Report
por: Jadvani, Dharmikkumar, et al.
Publicado: (2023)

Native valve endocarditis due to Micrococcus luteus: a case report and review of the literature
por: Miltiadous, George, et al.
Publicado: (2011)

Olmesartan-medoxomil: Sprue-like enteropathy: case report
Publicado: (2021)

Rare Case of Olmesartan Induced Enteropathy
por: Handa, Richa, et al.
Publicado: (2017)

Enteropathy Associated with Olmesartan
por: Silva, Bruno Moreira da, et al.
Publicado: (2015)

Effects of increased body weight and short-term weight loss on serum PCSK9 levels – a prospective pilot study
por: Filippatos, Theodosios D, et al.
Publicado: (2017)

Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study
por: Martinez-Martin, F J, et al.
Publicado: (2011)

Olmesartan: Induced maculopapular rash
por: Bhushan, Aruna, et al.
Publicado: (2013)

Enteropatía secundaria a olmesartán
por: Curieses Luengo, María, et al.
Publicado: (2017)

Olmesartan-Induced Enteropathy: A Case of Recurrent Diarrhoea
por: Fernandes Matos, Ana Rita, et al.
Publicado: (2020)

Vasopressin for persistent hypotension due to amlodipine and olmesartan overdose: A case report
por: Matsushime, Susumu, et al.
Publicado: (2021)

Olmesartan-Induced Sprue Like Enteropathy
por: Carneiro, Liliana, et al.
Publicado: (2016)

Hydrochlorothiazide/ibuprofen/olmesartan medoxomil: Drug misuse and acute tubular injury: case report
Publicado: (2021)

Difference in the effects of switching from Candesartan to Olmesartan or Telmisartan to Olmesartan in hypertensive patients with type 2 diabetes: the COTO study
por: Daikuhara, Hiroyuki, et al.
Publicado: (2014)

Olmesartan: A Little-Known Cause of Diarrhoea
por: Serôdio, Joana, et al.
Publicado: (2019)

Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension
por: Greathouse, Mark
Publicado: (2006)

Spectrophotometric Estimation of Olmesartan Medoxomil and Hydrochlorothiazide in Tablet
por: Rote, A. R., et al.
Publicado: (2010)

Olmesartan medoxomil for the treatment of hypertension in children and adolescents
por: Tocci, Giuliano, et al.
Publicado: (2011)

Formulation and Evaluation of Liquisolid Compacts for Olmesartan Medoxomil
por: Prajapati, Shailesh T., et al.
Publicado: (2013)

Combination Therapy with Olmesartan and Amlodipine in the Treatment of Hypertension
por: Niemeijer, Menco G., et al.
Publicado: (2009)

Olmesartan‐induced enteropathy associated with cutaneous lesions
por: Hammoudi, Nassim, et al.
Publicado: (2016)

Management of Hypertension Using Olmesartan Alone or in Combination
por: Zhang, Xiaoshen, et al.
Publicado: (2017)

Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial
por: Takami, Takeshi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1qls3d4plmm57aeg1g7tnu19cl